However, the clinical value of these and other biomarkers, such as dipeptidyl peptidase-3 (DPP3, a biomarker of inflammatory and oxidative stress associated with decreased myocardial contractility) in cardiogenic shock, requires validation in larger studies. Here, DPP3 is linked to Shock.